STOP THE PROGRESSION
Have you been diagnosed with COVID-19?
Do you have any of these symptoms? Cough or difficulty breathing, fever, muscle pain, loss of smell.You could be eligible to participate in the government-funded clinical trial called "COLCORONA".
For more information or to take part in the trial,
contact your healthcare professional or call
Daily intake of study medication or placebo
2 follow-up calls or video-visits are required
Be 40 years old
Forbidden to pregnant women, or who are breastfeeding, or who do not use contraception (pre-menopausal)
We are conducting a clinical trial to determine whether a short-term treatment with a medication reduces the risk of death and lung complications related to COVID-19.
A new coronavirus is responsible for causing coronavirus disease (COVID-19). While the majority of cases are mild, a certain number of people progress to severe disease with complications.
Adults who suffer major COVID-19 complications appear to present a major inflammatory storm (overreaction of immune system). Therefore, we hypothesize that targeting the inflammatory response (originating from the inflammasome) may reduce COVID-19-related complications in adults at risk or with evidence of an inflammatory storm.
The primary objective of the COLCORONA study is to determine whether short-term treatment with a particular medication reduces the rate of death and lung complications related to COVID-19. COLCORONA will be a randomized, double-blind, placebo-controlled study. Following signature of the informed consent form, 6000 subjects meeting all inclusion and no exclusion criteria will be enrolled.
Dr. Jean-Claude Tardif
Director of the Research Centre at the Montréal Heart Institute
Every donation counts!
Copyright © 2020 - All rights reserved - www.colcorona.org